SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 5, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago
Insider cluster: 3 insiders, $6.3M total
Actionable Insight • Neutral

Insider selling at 0.02% of market cap is quantitatively trivial and does not signal a bearish view, even with CEO participation. Monitor for any follow-on 10b5-1 plan adoption or larger multiday CEO selling pattern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$213.47
T+0 close · Jun 5, 2026 · via day close
Latest settled
+32.95%
T+20 · $283.80
Vs SPY
+31.31%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · Jun 8 $213.47entry
  2. T+1 · 5mo ago +4.38%α +4.67% · $222.82
  3. T+5 · 5mo ago +1.64%α −0.47% · $216.97
  4. T+20 · 4mo ago +32.95%α +31.31% · $283.80
  5. T+60 · due 3mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three NTRA insiders, including the CEO and director, collectively sold $6.34M in open-market sales over a 4-day window. The total represents ~0.02% of the $31.8B market cap, which is trivial.

Key Financial Metrics

Direction
selling
Total Value
$6.3M
Insiders
3

Key Facts

  • 3 insiders sold $6.34M total in open-market sales between Jun 1-4, 2026
  • CEO Steven Chapman sold 832 shares worth ~$177K
  • Director Roelof Botha sold 26,411 shares worth ~$5.78M (91% of total)
  • President Solomon Moshkevich sold 1,802 shares worth ~$392K
  • Total sales represent 0.02% of Natera's $31.8B market cap
  • All 3 trades are open-market sales (code S)

Financial Impact

$6.34M in insider sales, trivial relative to $31.8B market cap at 0.02%

insider ownership percentage

Risk Factors

  • CEO and director selling could be perceived negatively by momentum traders
  • Botha's large $5.78M sale may be diversification-driven (director, not C-suite)

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NTRA-1780707947897

Track record

63 reports on NTRA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
  2. Nov 10, 20265d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
  3. Nov 10, 20265d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
  5. Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
  6. Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
  7. Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
  8. Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
Showing 10 of 63

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026